BoughtonCK, AllenJM, WareJ, et al.Closed-loop therapy and preservation of c-peptide secretion in type 1 diabetes. N Engl J Med, 2022 Sep 8;387(10):882–893.
2.
McVeanJ, ForlenzaGP, BeckRW, et al.Effect of tight glycemic control on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: A randomized clinical trial. JAMA, 2023; 329(12):980–989.
3.
LachinJM, BebuI, NathanDM. The beneficial effects of earlier versus later implementation of intensive therapy in type 1 diabetes. Diabetes Care, 2021; 44(10):2225–2230.
4.
ChenNS, BoughtonCK, HartnellS, et al.User engagement with the camaps fx hybrid closed-loop app according to age and user characteristics. Diabetes Care, 2021; 44(7):e148–e50.
5.
RankinD, KimbellB, HovorkaR, et al.Adolescents' and their parents' experiences of using a closed-loop system to manage type 1 diabetes in everyday life: Qualitative study. Chronic Illn, 2022; 18(4):742–756.
